Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Jul 26, 2023 $18.90 $19.19 $18.55 $18.72 566 233
Jul 25, 2023 $20.01 $20.02 $18.96 $18.97 658 351
Jul 24, 2023 $20.41 $20.75 $19.75 $20.12 1 163 922
Jul 21, 2023 $20.60 $21.09 $19.86 $20.50 808 257
Jul 20, 2023 $21.79 $22.43 $20.34 $20.50 1 286 623
Jul 19, 2023 $22.43 $22.63 $21.71 $21.76 401 648
Jul 18, 2023 $22.96 $23.27 $21.95 $22.16 604 978
Jul 17, 2023 $22.64 $23.14 $22.27 $22.93 859 591
Jul 14, 2023 $21.22 $22.32 $21.01 $22.22 812 860
Jul 13, 2023 $20.19 $21.59 $20.16 $21.42 1 153 077
Jul 12, 2023 $20.78 $20.92 $19.98 $20.10 1 355 300
Jul 11, 2023 $19.70 $22.21 $19.62 $20.50 4 735 534
Jul 10, 2023 $23.39 $24.68 $23.23 $24.52 510 698
Jul 07, 2023 $23.31 $23.75 $23.11 $23.34 354 959
Jul 06, 2023 $24.36 $24.36 $23.18 $23.28 524 712
Jul 05, 2023 $24.68 $24.84 $23.81 $24.31 520 826
Jul 03, 2023 $23.72 $25.05 $23.64 $24.70 402 082
Jun 30, 2023 $24.20 $24.59 $23.64 $23.79 818 187
Jun 29, 2023 $23.91 $24.15 $23.70 $23.94 605 739
Jun 28, 2023 $23.88 $24.24 $23.59 $23.94 506 951
Jun 27, 2023 $23.64 $23.93 $22.98 $23.78 848 153
Jun 26, 2023 $25.57 $25.57 $23.14 $23.61 698 775
Jun 23, 2023 $26.36 $26.76 $25.60 $25.72 798 710
Jun 22, 2023 $26.84 $27.45 $25.86 $26.66 854 829
Jun 21, 2023 $24.96 $27.50 $24.96 $27.04 594 670
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT